Skip to content
MARKETS / NYSE / XRN
NYSE · REAL ESTATE INVESTMENT TRUSTS · MID CAP

Chiron Real Estate Inc. XRN

14 fiscal years on record · USD · FY2025 reported · SEC filings only
$526,000
▲ 42.2% YoY
$-6.9M
▼ 202.9% YoY
In brief

What this company does

We hold our facilities and conduct our operations through a Delaware limited partnership subsidiary, Chiron Real Estate LP (the “Operating Partnership”). Our business strategy is to invest primarily in healthcare properties that provide an attractive rate of return relative to our cost of capital and are operated by profitable physician groups, regional or national healthcare systems or combinations thereof. As of December 31, 2025, we had gross investments of approximately $1.5 billion in real estate properties, consisting of 189 buildings with an aggregate of (i) approximately 5.1 million leasable square feet and (ii) approximately $118.8 million of annualized base rent. Most of our healthcare facilities are leased to single-tenants under triple-net leases.

Written from the business description in Chiron Real Estate Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 2 March 2026. Every sentence was checked against that document before publication.

Growth
USD 526,000.00
Revenue, FY2025 · full 14-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.5 · Net income -6.9
8.0M16.0M-2.5M-5.0M20122014201620182020202220242025
Compound annual growth
+65.5%
+19.9%
−12.8%
+26.6%
+15.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +19.9% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−1309 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Net -1308.6%
10000%20000%-2000%-4000%20122014201620182020202220242025
ROE
FY2025 · ROE -1.3%
-100%-200%20122014201620182020202220242025

Each USD of equity lost 1 cents this year.

Cash & shareholders
USD 11.8M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2015 · FCF -32.0
-20M20122014201620182020202220242025
Net buybacks $M Dividends $M
FY2025 · Dividends 5.8 · Net buybacks 6.0
4M8MDividendsNet buybacks2014201620182020202220242025

USD 5.8M in dividends and USD 6.0M in buybacks went back to shareholders in a year without profit.

Total assetsUSD 1.2B
EquityUSD 509.8M
CashUSD 9.1M
Gross debtUSD 1.2M
Net debtUSD -7.9M

The company holds more cash than debt.

The 14-year record
14 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.0·
Operating income $B··············
EBITDA $B··············
Income tax $B·············0.0
Net income $B−0.00.00.00.00.0−0.00.00.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B··········−0.0−0.0··
EPS, diluted $−0.910.061.130.200.19−0.170.100.35−0.09−0.68−6.44−13.49−2.320.01
Dividend / sh $·4.204.200.840.820.800.800.800.800.09····
Payout %−8587272932−2336140−856−0−0−7··
ROE %−1.31.23.63.23.4−0.62.75.6−0.0−8.2−202.7−76.3·−169.9
Shares out B0.010.010.070.070.060.050.000.000.020.020.000.000.000.01

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 42 reconciliationsAUDITED

Reconciled in 15 of 19 fiscal years. 34 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityReal Estate Investment Trusts
Listed onNYSE
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2011

Share this section

Download image